NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

高分子生物分析技術的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品、技術 (層析法、電泳)、用途、地區

Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report By Product, By Technology (Chromatography, Electrophoresis), By Application, By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1007456
出版日期 內容資訊 英文 258 Pages
商品交期: 2-10個工作天內
價格
高分子生物分析技術的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品、技術 (層析法、電泳)、用途、地區 Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report By Product, By Technology (Chromatography, Electrophoresis), By Application, By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年05月05日內容資訊: 英文 258 Pages
簡介

全球高分子生物分析技術的市場規模在預測期間內預計以13.5%的年複合成長率發展,2028年成長到139億美元的規模。

生物醫藥品相關的R&D及投資的活躍促進該市場的成長。還有新型冠狀病毒感染疾病 (COVID-19)的全球性流行,導致主要經營者的製造能力和R&D能力的擴大,對生物分析實驗服務的需求也提高。再加上疫苗和細胞基因治療的開發使用先進技術,也導致該市場的大幅成長。

本報告提供全球高分子生物分析技術的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,市場規模的變化、預測,產品&服務、技術、治療區分、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 摘要整理

第2章 調查手法

第3章 市場可變因素、趨勢、展望

  • 市場預測
  • 市場分類、範圍
  • 市場動態
  • COVID-19:影響分析
  • 普及、成長預測製圖
  • 波特五力分析

第4章 市場預測、趨勢分析:各產品、服務

  • 產品
  • 服務

第5章 市場預測、趨勢分析:各技術

  • 電泳
  • 層析法
  • 質譜分析
  • 西方墨點法
  • ddPCR、qPCR、RT-PCR
  • ELISA
  • 流式細胞技術
  • 分光計
  • 分析用超離心法
  • 光散亂 (MALS、DLS)、靜態光散亂
  • DNA定序
  • 其他

第6章 市場預測、趨勢分析:各治療種類

  • 生技藥品
  • 細胞、核酸療法
  • 病毒載體
  • 基因治療
  • 奈米聚合物粒子

第7章 市場預測、趨勢分析:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭分析

  • 業者情勢
  • 策略性架構
  • 企業的分類
  • 企業簡介
目錄
Product Code: GVR-4-68039-425-9

Large Molecule Bioanalytical Technologies Market Growth & Trends

The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Large Molecule Bioanalytical Technologies Market Report Highlights

The product segment accounted for the largest revenue share in 2020

Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing

Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth

Mass spectrometry captured the maximum revenue share in 2020 due to the diversification of products as well as their frequent usage

This technology has been conventionally used in the development of protein pharmaceuticals, for instance, in the analysis of confirmations of amino acids in proteins

Furthermore, quantitative PCR (qPCR) is widely adopted in the detection of viral contaminants during the manufacture of biopharmaceuticals

Thus, with the growing demand for viral vectors, this technology is anticipated to witness the fastest growth over the forecast period

Moreover, the presence of a wide array of products in spectrometry is one of the key industry factors driving investment in the segment

Biologics accounted for the major revenue share in 2020 owing to the ever-expanding R&D activity programs in the segment

Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services

The COVID-19 pandemic has accelerated the development of genetic vaccines

This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment

North America dominated the market in 2020 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing

Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region

In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront

Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region

Key companies are focusing on new product launches to sustain their position in the market

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Summary

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Information or Data Analysis
    • 2.2.1 Market study
      • 2.2.1.1 KOL Opinions
      • 2.2.1.1.1 KOL Opinions: Downside Scenario
      • 2.2.1.1.2 KOL Opininos: Future market landscape
      • 2.2.1.1.3 KOL Opinions: Technological development
      • 2.2.1.2 Technology Study

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlooK
    • 3.1.2 Ancillary market outlooK
      • 3.1.2.1 Protein Stability Analysis Market: Market Outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market driver Analysis
      • 3.3.1.1 Technological advancements in life science tools and analytical instruments
      • 3.3.1.2 Rising collaboration between operating stakeholders
      • 3.3.1.3 Rising advancements, automation, and expansion in laboratory facilities
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Timeline, speed & cost-related challenges
      • 3.3.2.2 Complicated bioanalytical assays due to complex nature of large molecules
      • 3.3.2.3 Challenges associated with sample preparation
    • 3.3.3 Market Opportunity Analysis
      • 3.3.3.1 Vaccine development against SARS-CoV-2 infection
      • 3.3.3.2 Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
      • 3.3.3.2.1 Notable growth of biologics & biosimilars
    • 3.3.4 Market threat Analysis
      • 3.3.4.1 Dominance of small molecule
  • 3.4 COVID-19 Impact analysis
    • 3.4.1 Short-term impact
    • 3.4.2 Long-term impact
    • 3.4.3 Challenge Analysis
    • 3.4.4 Opportunity Analysis
      • 3.4.4.1 Key developments & activities
  • 3.5 Penetration & Growth Prospect Mapping for Therapeutic Applications, 2020
  • 3.6 Porter's Analysis
  • 3.7 COVID-19 Impact Analysis

Chapter 4 Product & Service Business Analysis

  • 4.1 Market: Product & Service Movement Analysis
  • 4.2 Products
    • 4.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 4.2.2 Consumables & Accessories
      • 4.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 4.2.3 Instruments
      • 4.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 4.2.4 Reagents & Kits
      • 4.2.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
  • 4.3 Services
    • 4.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 5 Technology Business Analysis

  • 5.1 Market: Technology Movement Analysis
  • 5.2 Electrophoresis
    • 5.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.3 Chromatography
    • 5.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.4 Mass Spectrometry
    • 5.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.5 Western Blot
    • 5.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.6 ddPCR, qPCR, RT-PCR
    • 5.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.7 ELISA
    • 5.7.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.8 Flow Cytometry
    • 5.8.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.9 Spectrometer
    • 5.9.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.9.2 UV/Vis
      • 5.9.2.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.9.3 CD
      • 5.9.3.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.9.4 Raman
      • 5.9.4.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.9.5 Laser-induced breakdown spectroscopy
      • 5.9.5.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.9.6 Other Spectroscopy techniques
      • 5.9.6.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.10 Analytical ultracentrifugation
    • 5.10.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.11 Light scattering (MALS, DLS) & static light scattering
    • 5.11.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.12 DNA Sequencing
    • 5.12.1 Market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.13 Other Technologies
    • 5.13.1 Market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 6 Therapeutic Application Business Analysis

  • 6.1 Market: Therapeutic Application Movement Analysis
  • 6.2 Biologics
    • 6.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 6.2.2 By Type
      • 6.2.2.1 mAbs
      • 6.2.2.1.1 Market estimates and forecast, 2017 - 2028 (USD Million)
      • 6.2.2.2 Vaccines
      • 6.2.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
      • 6.2.2.3 Recombinant proteins
      • 6.2.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 6.2.3 By Technology
      • 6.2.3.1 Spectrometer
      • 6.2.3.1.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.2 Western Blot
      • 6.2.3.2.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.3 Isoelectric Focusing
      • 6.2.3.3.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.4 Capillary Electrophoresis
      • 6.2.3.4.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.5 Peptide mapping and sequencing by LC-MS/MS
      • 6.2.3.5.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.6 Peptide fingerprinting by Chromatography and Mass Spectrometry (MS)
      • 6.2.3.6.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.7 ddPCR, qPCR, RT-PCR
      • 6.2.3.7.1 Market analysis, 2017 - 2028 (USD Million)
      • 6.2.3.8 Other Technologies
      • 6.2.3.8.1 Market analysis, 2017 - 2028 (USD Million)
  • 6.3 Cell & Nucleic Acid Therapy
    • 6.3.1 Market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
    • 6.3.2 SDS-PAGE or Capillary Electrophoresis
      • 6.3.2.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.3 Chromatography
      • 6.3.3.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.4 Mass Spectrometry/LC-MS
      • 6.3.4.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.5 UV/Vis Spectrometry
      • 6.3.5.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.6 ddPCR, qPCR, RT-PCR
      • 6.3.6.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.7 ELISA Assays
      • 6.3.7.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.8 Fluroscent Assays
      • 6.3.8.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.9 Luminescent Assays
      • 6.3.9.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.10 Western Blot
      • 6.3.10.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.11 Flow cytometry
      • 6.3.11.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.3.12 Other technologies
      • 6.3.12.1 Market analysis, 2017 - 2028 (USD Million)
  • 6.4 Viral Vector
    • 6.4.1 Market estimates and forecast for viral vector, 2017 - 2028 (USD Million)
    • 6.4.2 Sanger
      • 6.4.2.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.3 ddPCR, qPCR, RT-PCR
      • 6.4.3.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.4 ELISA
      • 6.4.4.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.5 Electrophoresis
      • 6.4.5.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.6 NGS
      • 6.4.6.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.7 Mass Spectrometry
      • 6.4.7.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.8 Chromatography
      • 6.4.8.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.9 Dynamic & Static light scattering
      • 6.4.9.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.4.10 Other Technologies
      • 6.4.10.1 Market analysis, 2017 - 2028 (USD Million)
  • 6.5 Gene Therapy
    • 6.5.1 Market Estimates And Forecast For Gene Therapy, 2017 - 2028 (USD Million)
    • 6.5.2 SDS-PAGE or Capillary Electrophoresis
      • 6.5.2.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.3 Chromatography
      • 6.5.3.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.4 Mass Spectrometry/LC-MS
      • 6.5.4.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.5 UV/Vis Spectrometry
      • 6.5.5.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.6 ddPCR, qPCR, RT-PCR
      • 6.5.6.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.7 ELISA Assays
      • 6.5.7.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.8 Fluroscent Assays
      • 6.5.8.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.9 Luminescent Assays
      • 6.5.9.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.10 Western Blot
      • 6.5.10.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.11 Flow cytometry
      • 6.5.11.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.5.12 Other technologies
      • 6.5.12.1 Market analysis, 2017 - 2028 (USD Million)
  • 6.6 Nanoparticles and Polymers
    • 6.6.1 Market Estimates And Forecast For Nanoparticles And Polymers, 2017 - 2028 (USD Million)
    • 6.6.2 Dynamic & static light scattering
      • 6.6.2.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.6.3 Lasser Diffraction
      • 6.6.3.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.6.4 Fluroscence Spectrometry
      • 6.6.4.1 Market analysis, 2017 - 2028 (USD Million)
    • 6.6.5 Other Technologies
      • 6.6.5.1 Market analysis, 2017 - 2028 (USD Million)

Chapter 7 Regional Business Analysis

  • 7.1 Market: Regional Movement Analysis, 2020 & 2028
  • 7.2 North America
    • 7.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.2.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Milliion)
    • 7.2.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
    • 7.2.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.2.2.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.2.2.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.2.3.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.2.3.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.3.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
    • 7.3.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
    • 7.3.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.3.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.3.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.6 U.K.
      • 7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.6.2 Market estimates land forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.7 France
      • 7.6.7.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.8 Italy
      • 7.6.8.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.9 Spain
      • 7.6.9.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.9.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.9.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.4.2 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
    • 7.4.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
    • 7.4.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.4.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.4.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.4.6 China
      • 7.4.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.4.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.4.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
      • 7.4.7.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.4.7.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market estimates and forecast, by product &service, 2017 - 2028 (USD Million)
      • 7.4.8.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.4.8.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.5.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
    • 7.5.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
    • 7.5.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.5.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.5.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.5.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.5.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
  • 7.6 Middle East and Africa (MEA)
    • 7.6.1 Market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.6.2 Market estimates and forecast, by product & services, 2017 - 2028 (USD Million)
    • 7.6.3 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
    • 7.6.4 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.5.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.5.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market estimates and forecast, by product & service, 2017 - 2028 (USD Million)
      • 7.6.6.2 Market estimates and forecast, by technology, 2017 - 2028 (USD Million)
      • 7.6.6.3 Market estimates and forecast, by application, 2017 - 2028 (USD Million)

Chapter 8 Competitve Analysis

  • 8.1 Large Molecule Bioanalytical Technologies Market: Vendor Landscape
  • 8.2 Strategy Framework
  • 8.3 Company Categorization
  • 8.4 Company Profiles - Large Molecule Stability Market
    • 8.4.1 Intertek Group plc.
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 SOLVIAS AG
      • 8.4.2.1 Company overview
      • 8.4.2.2 Product benchmarking
      • 8.4.2.3 Strategic initiatives
    • 8.4.3 Bio-Techne Corporation
      • 8.4.3.1 Company overview
      • 8.4.3.2 ProteinSimple
      • 8.4.3.3 Financial Performance
      • 8.4.3.4 Product benchmarking
      • 8.4.3.5 Strategic initiatives
    • 8.4.4 Wyatt Technology Corporation
      • 8.4.4.1 Company overview
      • 8.4.4.2 Product benchmarking
      • 8.4.4.3 Strategic initiatives
    • 8.4.5 Precision NanoSystems
      • 8.4.5.1 Company overview
      • 8.4.5.2 Product benchmarking
    • 8.4.6 Verder
      • 8.4.6.1 Company overview
      • 8.4.6.2 Product benchmarking
      • 8.4.6.3 Strategic initiatives
    • 8.4.7 Halo Labs
      • 8.4.7.1 Company overview
      • 8.4.7.2 Product benchmarking
      • 8.4.7.3 Strategic initiatives
    • 8.4.8 Charles River Laboratories International, Inc.
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 Avomeen
      • 8.4.9.1 Company overview
      • 8.4.9.2 Product benchmarking
      • 8.4.9.3 strategic initiatives
    • 8.4.10 Merck KGaA
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives
    • 8.4.11 Cergentis B.V.
      • 8.4.11.1 Company overview
      • 8.4.11.2 Product benchmarking
      • 8.4.11.3 strategic initiatives
    • 8.4.12 Laboratory Corporation of America Holdings
      • 8.4.12.1 Company overview
      • 8.4.12.2 Covance
      • 8.4.12.3 Financial Performance
      • 8.4.12.4 Product benchmarking
      • 8.4.12.5 Strategic initiatives
    • 8.4.13 DH Tech. Dev. Pte. Ltd. (SCIEX)
      • 8.4.13.1 Company overview
      • 8.4.13.2 Product benchmarking
      • 8.4.13.3 Strategic initiatives
    • 8.4.14 F. Hoffmann-La Roche Ltd
      • 8.4.14.1 Company overview
      • 8.4.14.2 Financial Performance
      • 8.4.14.3 Product benchmarking
      • 8.4.14.4 Strategic initiatives
    • 8.4.15 Bio-Rad Laboratories, Inc.
      • 8.4.15.1 Company overview
      • 8.4.15.2 Financial Performance
      • 8.4.15.3 Product benchmarking
      • 8.4.15.4 Strategic initiatives

List of Tables

  • Table 1 Company mapping for Large molecule bioanalytical technologies analysis, by technology
  • Table 2 Company mapping for Large molecule bioanalytical technologies analysis, by molecule type
  • Table 3 List of key technology supplier
  • Table 4 Some commercially available portable and handheld instruments
  • Table 5 Pandemic-related changes or trends in long term
  • Table 6 Testing types and methods
  • Table 7 Overview of analytical methods used in viral vector manufacturing
  • Table 8 North America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 9 North America large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 10 North America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 11 North America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 12 North America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 13 North America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 14 North America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 15 North America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 16 North America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 17 North America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 18 North America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 19 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 20 U.S. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 21 U.S. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 22 U.S. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 23 U.S. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 24 U.S. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 25 U.S. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 26 U.S. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 27 U.S. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 28 U.S. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 29 U.S. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 30 Canada large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 31 Canada large molecule bioanalytical technologies product & service market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 32 Canada large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 33 Canada spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 34 Canada large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 35 Canada biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 36 Canada biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 37 Canada viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 38 Canada cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 39 Canada gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 40 Canada nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 41 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 42 Europe. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 43 Europe large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 44 Europe spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 45 Europe large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 46 Europe biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 47 Europe biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 48 Europe viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 49 Europe cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 50 Europe gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 51 Europe nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 52 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 53 Germany. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 54 Germany large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 55 Germany spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 56 Germany large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 57 Germany biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 58 Germany biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 59 Germany viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 60 Germany cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 61 Germany gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 62 Germany nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 63 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 64 U.K. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 65 U.K. large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 66 U.K. spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 67 U.K. large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 68 U.K. biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 69 U.K. biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 70 U.K. viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 71 U.K. cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 72 U.K. gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 73 U.K. nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 74 France. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 75 France large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 76 France large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 77 France spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 78 France large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 79 France biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 80 France biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 81 France viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 82 France cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 83 France gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 84 France nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 85 Italy large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 86 Italy large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 87 Italy large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 88 Italy spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 89 Italy large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 90 Italy biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 91 Italy biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 92 Italy viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 93 Italy cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 94 Italy gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 95 Italy nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 96 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 97 Spain. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 98 Spain large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 99 Spain spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 100 Spain large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 101 Spain biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 102 Spain biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 103 Spain viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 104 Spain cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 105 Spain gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 106 Spain nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 107 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 108 Asia Pacific. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 109 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 110 Asia Pacific spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 111 Asia Pacific large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 112 Asia Pacific biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 113 Asia Pcific biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 114 Asia Pacific viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 115 Asia Pacific cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 116 Asia Pacific gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 117 Asia Pacific nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 118 Japan large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 119 Japan large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 120 Japan large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 121 Japan spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 122 Japan large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 123 Japan biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 124 Japan biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 125 Japan viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 126 Japan cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 127 Japan gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 128 Japan nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 129 China large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 130 China large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 131 China large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 132 China spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 133 China large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 134 China biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 135 China biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 136 China viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 137 China cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 138 China gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 139 China nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 140 India large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 141 India large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 142 India large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 143 India spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 144 India large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 145 India biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 146 India biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 147 India viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 148 India cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 149 India gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 150 India nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 151 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 152 South Korea large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 153 South Korea large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 154 South Korea spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 155 South Korea large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 156 South Korea biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 157 South Korea biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 158 South Korea viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 159 South Korea cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 160 South Korea gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 161 South Korea nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 162 Latin America large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 163 Latin America. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 164 Latin America large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 165 Latin America spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 166 Latin America large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 167 Latin America biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 168 Latin America biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 169 Latin America viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 170 Latin America cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 171 Latin America gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 172 Latin America nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 173 Brazil large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 174 Brazil. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 175 Brazil large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 176 Brazil spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 177 Brazil large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 178 Brazil biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 179 Brazil biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 180 Brazil viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 181 Brazil cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 182 Brazil gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 183 Brazil nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 184 Mexico large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 185 Mexico. large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 186 Mexico large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 187 Mexico spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 188 Mexico large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 189 Mexico biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 190 Mexico biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 191 Mexico viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 192 Mexico cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 193 Mexico gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 194 Mexico nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 195 MEA large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 196 MEA large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 197 MEA large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 198 MEA spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 199 MEA large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 200 MEA biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 201 MEA biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 202 MEA viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 203 MEA cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 204 MEA gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 205 MEA nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 206 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 207 South Africa large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 208 South Africa large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 209 South Africa spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 210 South Africa large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 211 South Africa biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 212 South Africa biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 213 South Africa viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 214 South Africa cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 215 South Africa gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 216 South Africa nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 217 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product & service, 2017 - 2028 (USD Million)
  • Table 218 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 219 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 220 Saudi Arabia spectrometry market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 221 Saudi Arabia large molecule bioanalytical technologies market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 222 Saudi Arabia biologics market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 223 Saudi Arabia biologics market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 224 Saudi Arabia viral vector market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 225 Saudi Arabia cell & nucleic acid therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 226 Saudi Arabia gene therapy market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • Table 227 Saudi Arabia nanoparticles & polymers market estimates & forecasts, by technology, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Large molecule bioanalytical technologies market, 2020 (USD Million)
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research
  • Fig. 5 Primary research validation
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model assessment
  • Fig. 9 Industry pyramid analysis
  • Fig. 10 Market landscape
  • Fig. 11 KOL opinions: Downside Scenario
  • Fig. 12 KOL opinions: Future market landscape
  • Fig. 13 KOL opinions: Technological development
  • Fig. 14 Comparing protein stability analysis platforms
  • Fig. 15 Analytical method analysis
  • Fig. 16 Impact analysis of new developments by key market participants
  • Fig. 17 Summary of spectrometry techniques
  • Fig. 18 Number of biopharmaceutical products approved by the U.S.FDA (1982 - 2018)
  • Fig. 19 Large molecule bioanalytical technologies market segmentation
  • Fig. 20 Market driver relevance analysis (Current & future impact)
  • Fig. 21 Overview of manufacturing processes and technology innovation
  • Fig. 22 Market threat relevance analysis (Current & future impact)
  • Fig. 23 Number of recombinant and non-recombinant biopharmaceuticals approved by FDA, 2016 - 2019
  • Fig. 24 CDER BLA approvals of biologics & biosimilars
  • Fig. 25 Penetration & growth prospect mapping for therapeutic applications, 2020
  • Fig. 26 Large molecule bioanalytical technologies market Porter's five forces analysis
  • Fig. 27 Large molecule bioanalytical technologies market: Product & service outlook key takeaways
  • Fig. 28 Large molecule bioanalytical technologies market: Product & service movement analysis
  • Fig. 29 Product market, 2017 - 2028 (USD Million)
  • Fig. 30 Consumables & accessories market, 2017 - 2028 (USD Million)
  • Fig. 31 Instruments market, 2017 - 2028 (USD Million)
  • Fig. 32 Reagents & kits market, 2017 - 2028 (USD Million)
  • Fig. 33 Service market, 2017 - 2028 (USD Million)
  • Fig. 34 Large molecule bioanalytical technologies market: Technology outlook key takeaways
  • Fig. 35 Overview of analytical tools used in viral vector manufacturing
  • Fig. 36 Large molecule bioanalytical technologies market: Technology movement analysis
  • Fig. 37 Electrophoresis techniques used in quality control of biologics
  • Fig. 38 Electrophoresis market, 2017 - 2028 (USD Million)
  • Fig. 39 Chromatography market, 2017 - 2028 (USD Million)
  • Fig. 40 Mass spectrometry market, 2017 - 2028 (USD Million)
  • Fig. 41 Key applications of quantitative western blotting for manufacture of biopharma
  • Fig. 42 Western blot market, 2017 - 2028 (USD Million)
  • Fig. 43 ddPCR, qPCR, RT-PCR market, 2017 - 2028 (USD Million)
  • Fig. 44 Technologies used for QC testing & characterization of AAV gene therapy vector
  • Fig. 45 ELISA market, 2017 - 2028 (USD Million)
  • Fig. 46 Flow cytometry market, 2017 - 2028 (USD Million)
  • Fig. 47 Spectroscopy market, 2017 - 2028 (USD Million)
  • Fig. 48 UV/VIS spectroscopy market, 2017 - 2028 (USD Million)
  • Fig. 49 CD spectroscopy market, 2017 - 2028 (USD Million)
  • Fig. 50 Integration of Raman spectroscopy during biopharma production
  • Fig. 51 Raman spectroscopy market, 2017 - 2028 (USD Million)
  • Fig. 52 Laser-induced breakdown spectroscopy market, 2017 - 2028 (USD Million)
  • Fig. 53 Other spectroscopy techniques market, 2017 - 2028 (USD Million)
  • Fig. 54 Key application areas of analytical ultracentrifugation
  • Fig. 55 Analytical ultracentrifugation market, 2017 - 2028 (USD Million)
  • Fig. 56 Light scattering (MALS, DLS) & static light scattering market, 2017 - 2028 (USD Million)
  • Fig. 57 DNA sequencing market, 2017 - 2028 (USD Million)
  • Fig. 58 Other technologies market, 2017 - 2028 (USD Million)
  • Fig. 59 Large molecule bioanalytical technologies market: Therapeutic Application outlook and key takeaways
  • Fig. 60 Large molecule bioanalytical technologies market: Therapeutic application movement analysis
  • Fig. 61 Typical analytical methods used for development and release testing of biologic therapeutics
  • Fig. 62 Large molecule bioanalytical technologies market estimates and forecast for biologics, 2017 - 2028 (USD Million)
  • Fig. 63 Global MABs market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 64 Global recombinant proteins market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 65 Global vaccines market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 66 Global spectrometer-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 67 Global western blot-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 68 Global isoelectric focusing-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 69 Global capillary electrophoresis-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 70 Global peptide mapping and sequencing by LC-MS/MS-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 71 Global peptide fingerprinting by Chromatography and Mass Spectrometry (MS)-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 72 Global ddPCR,qPCR,RT-PCR-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 73 Global other technology-based biologics market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 74 Large molecule bioanalytical technologies market estimates and forecast for cell therapy, 2017 - 2028 (USD Million)
  • Fig. 75 Global SDS-PAGE or capillary gel electrophoresis-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 76 Global chromatography-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 77 Global mass spectrometry/LC-MS-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 78 Global UV-Vis Spectrometry assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 79 Global ddPCR,qPCR,RT-PCR-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 80 Global ELISA assay -based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 81 Global fluroscent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 82 Global luminescent assay-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 83 Global western-blot-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 84 Global flow cytometry-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 85 Global other technology-based cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 86 Large molecule bioanalytical technologies analysis estimates and forecast for viral vector 2017 - 2028 (USD Million)
  • Fig. 87 Global sanger-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 88 Global ddPCR,qPCR,RT-PCR-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 89 Global ELISA-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 90 Global electrophoresis-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 91 Global NGS-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 92 Global mass spectrometry-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 93 Global chromatograpgy-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 94 Global dynamic & static light scattering-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 95 Global other technologies-based viral vector market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 96 Large molecule bioanalytical technologies analysis estimates and forecast for gene therapy, 2017 - 2028 (USD Million)
  • Fig. 97 Global SDS-PAGE or capillary gel electrophoresis-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 98 Global chromatography-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 99 Global mass spectrometry/LC-MS-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 100 Global UV-Vis Spectrometry gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 101 Global ddPCR,qPCR,RT-PCR-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 102 Global ELISA assay -based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 103 Global fluroscent assay-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 104 Global luminescent assay-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 105 Global western-blot-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 106 Global flow cytometry-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 107 Global other technology-based gene therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 108 Nanoparticles analytical techniques
  • Fig. 109 Large molecule bioanalytical technologies analysis estimates and forecast for nanoparticles and polymers 2017 - 2028 (USD Million)
  • Fig. 110 Global dynamic & static light scattering-based nanoparticle & polymers market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 111 Global lasser diffraction-based nanoparticle & polymers market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 112 Global fluroscence spectrometry-based nanoparticle & polymers market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 113 Global other technology-based nanoparticle & polymers market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 114 Regional marketplace: Key takeaway
  • Fig. 115 Large molecule bioanalytical technologies market: Region movement analysis
  • Fig. 116 North America
  • Fig. 117 North America large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 118 U.S.
  • Fig. 119 U.S.large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 120 Canada
  • Fig. 121 Canada large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 122 Europe
  • Fig. 123 Europe large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 124 Germany
  • Fig. 125 Germany large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 126 U.K.
  • Fig. 127 U.K. large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 128 France
  • Fig. 129 France large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 130 Italy
  • Fig. 131 Italy large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 132 Spain
  • Fig. 133 Spain large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 134 Asia Pacific
  • Fig. 135 Asia Pacific large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 136 Japan
  • Fig. 137 Japan large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 138 China
  • Fig. 139 China large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 140 India
  • Fig. 141 India large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 142 South Korea
  • Fig. 143 South Korea large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 144 Latin America
  • Fig. 145 Latin America large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 146 Brazil
  • Fig. 147 Brazil large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 148 Mexico
  • Fig. 149 Mexico large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 150 Middle East & Africa (MEA)
  • Fig. 151 MEA large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 152 South Africa
  • Fig. 153 South Africa large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 154 Saudi Arabia
  • Fig. 155 Saudi Arabia large molecule bioanalytical technologies market estimates and forecast, 2017 - 2028 (USD Million)